Accéder au contenu
Merck

Evaluation of domifen bromide in the treatment of acute infectious oral diseases.

International journal of clinical pharmacology research (1983-01-01)
F Scaglione, G Scarpazza, E Marchi, G Biella, F Fraschini
RÉSUMÉ

By means of a double blind, placebo controlled trial, we have studied 29 patients (14 M and 15 F) affected by different acute infectious oral diseases. Our results suggest that domifen bromide may be useful in treating infectious oral diseases in combination with antibiotics, and in relieving pain and inflammation.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
Domiphen bromide, 97%